Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ROYALTY PHARMA PLC

(RPRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royalty Pharma, Floor & Decor Shares Climb as Berkshire Hathaway Buys Stakes

11/15/2021 | 06:23pm EST

By Patrick Chu

Shares of Royalty Pharma PLC and Floor & Decor Holdings Inc. gained in after-hours trading after Berkshire Hathaway Inc. disclosed it had bought stakes in the companies in the third quarter, according to Securities and Exchange filings released on Monday.

New York City-based Royalty Pharma is the largest buyer of biopharmaceutical royalties and went public at $28 a share on June 16. On Monday after the close, shares advanced 5.5% to $44. Berkshire bought 13.1 million shares in the third quarter, a new position for the investment company run by billionaire Warren Buffett.

In the same period, Berkshire bought 817,000 shares in Floor & Decor, a Smyrna, Ga.-based retailer that sells hard surface flooring and related products. Floor & Decor shares increased 7.6% to $139.89 in after-hours trading.

In the same set of filings, Berkshire revealed that it exited its prior positions in Merck & Co. Inc. and Liberty Global PLC.

To view Berkshire Hathaway's latest holdings, click here: http://www.sec.gov/Archives/edgar/data/1067983/000095012321015518/0000950123-21-015518-index.htm

To view holdings as of the previous quarter, click here: http://www.sec.gov/Archives/edgar/data/1067983/000095012321011396/0000950123-21-011396-index.htm

Write to Patrick Chu at Patrick.Chu@sWSJ.com

(END) Dow Jones Newswires

11-15-21 1823ET

Stocks mentioned in the article
ChangeLast1st jan.
BERKSHIRE HATHAWAY INC. 0.38% 463652 Delayed Quote.2.88%
FLOOR & DECOR HOLDINGS, INC. -1.57% 100.57 Delayed Quote.-22.64%
ROYALTY PHARMA PLC -0.51% 38.93 Delayed Quote.-2.31%
All news about ROYALTY PHARMA PLC
01/20Royalty Pharma to Announce Fourth-Quarter and Full-Year 2021 Financial Results on Febru..
AQ
01/10Royalty pharma and cytokinetics announce funding agreements totaling up to $450 million
AQ
01/10MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guida..
AQ
01/10ROYALTY PHARMA : HIGHLIGHTS ACCOMPLISHMENTS AND PROVIDES BUSINESS UPDATE AT 40TH ANNUAL J...
PU
01/10Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J..
AQ
01/07Health Care Stocks Slumping Near Friday Close
MT
01/07Health Care Stocks Nearing Break-Even Mark Following Afternoon Uptick
MT
01/07Health Care Stocks Retreat Premarket Friday
MT
01/07Cytokinetics Secures Up to $450 Million in Funding From Royalty Pharma for Heart Diseas..
MT
01/07Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million
GL
More news
Analyst Recommendations on ROYALTY PHARMA PLC
More recommendations
Financials (USD)
Sales 2021 2 127 M - -
Net income 2021 937 M - -
Net Debt 2021 4 623 M - -
P/E ratio 2021 25,3x
Yield 2021 1,78%
Capitalization 16 721 M 16 721 M -
EV / Sales 2021 10,0x
EV / Sales 2022 9,41x
Nbr of Employees -
Free-Float -
Chart ROYALTY PHARMA PLC
Duration : Period :
Royalty Pharma plc Technical Analysis Chart | RPRX | GB00BMVP7Y09 | MarketScreener
Technical analysis trends ROYALTY PHARMA PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 38,93 $
Average target price 51,50 $
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Pablo Gerardo Legorreta Chairman & Chief Executive Officer
Terrance Patrick Coyne Chief Financial Officer & Executive Vice President
James F. Reddoch Chief Scientific Officer
George Lloyd Executive VP-Investments & General Counsel
Errol B. de Souza Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ROYALTY PHARMA PLC-2.31%16 721
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642